Literature DB >> 24930774

Ethanol reduces lifespan, body weight, and serum alanine aminotransferase level of aldehyde dehydrogenase 2 knockout mouse.

Akiko Matsumoto1, Vasilis Vasiliou, Toshihiro Kawamoto, Keitaro Tanaka, Masayoshi Ichiba.   

Abstract

BACKGROUND: The aldehyde dehydrogenase 2 (Aldh2) knockout mouse is an animal model of a polymorphism at the human ALDH2 locus (ALDH2*2). To detect differences in the basic phenotype of this animal model, lifespan, body weight (BW), and serum alanine aminotransferase (ALT) level were evaluated.
METHODS: Aldh2(+/+) , Aldh2(+/-) , and Aldh2(-/-) mice were maintained, from 10 weeks of age, on standard solid food, with liquid supplied as ethanol (EtOH) solution at a concentration of 0 to 20% (forced EtOH consumption).
RESULTS: For animals provided with water (without EtOH), mice of the distinct genotypes exhibited no difference in lifespan, with the mean values ranging from 90 to 96 weeks for female mice and 97 to 105 weeks for male mice. For animals provided with EtOH, there was a dose-dependent reduction of lifespan in Aldh2(-/-) mice with p for trend <0.001. For example, the mean lifespans of the Aldh2(-/-) females in the 0, 3, 10, and 20% groups were 95, 85, 70, and 29 weeks, respectively. No influence on lifespan was found for Aldh2(+/+) and Aldh2(+/-) mice. BW and ALT level of Aldh2(-/-) mice were significantly lower than those of Aldh2(+/+) mice when the mice were treated with EtOH. While multiple regression analysis suggested that the BW and ALT level in Aldh2(-/-) mice correlated with lifespan, adjustment for EtOH concentration revealed that this correlation was not significant (i.e., reflected EtOH dependence).
CONCLUSIONS: Aldh2(-/-) mice were unchanged in terms of their basic phenotype under standard laboratory conditions. However, chronic EtOH administration (forced consumption) in these mice resulted in dose-dependent reductions in lifespan, BW, and serum ALT level.
Copyright © 2014 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alanine Aminotransferase; Aldehyde Dehydrogenase 2; Ethanol; Lifespan; Polymorphism

Mesh:

Substances:

Year:  2014        PMID: 24930774     DOI: 10.1111/acer.12462

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  4 in total

1.  Topically applied metal chelator reduces thermal injury progression in a rat model of brass comb burn.

Authors:  Cheng Z Wang; Amina El Ayadi; Juhi Goswamy; Celeste C Finnerty; Randy Mifflin; Linda Sousse; Perenlei Enkhbaatar; John Papaconstantinou; David N Herndon; Naseem H Ansari
Journal:  Burns       Date:  2015-09-29       Impact factor: 2.744

2.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

Review 3.  Engineered Animal Models Designed for Investigating Ethanol Metabolism, Toxicity and Cancer.

Authors:  Stephanie Marshall; Ying Chen; Surendra Singh; Pablo Berrios-Carcamo; Claire Heit; Nicholas Apostolopoulos; Jaya Prakash Golla; David C Thompson; Vasilis Vasiliou
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 4.  Roles of defective ALDH2 polymorphism on liver protection and cancer development.

Authors:  Akiko Matsumoto; David C Thompson; Ying Chen; Kyoko Kitagawa; Vasilis Vasiliou
Journal:  Environ Health Prev Med       Date:  2016-10-06       Impact factor: 3.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.